Example: Heart Attack

Search clinical trials for: Chenodeoxycholic Acid

Total 31 results

    • NCT03168555
      Completed
      Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
      Conditions: Bile Acid Malabsorption; Cholelithiasis
    • NCT03059537
      Completed
      Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
      Conditions: Bile Acid Malabsorption
    • NCT00912301
      Completed
      Cheno Effect on Transit in Health and IBS-C
      Conditions: Constipation-predominant Irritable Bowel Syndrome
    • NCT02952963
      Completed
      Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
      Conditions: Severe Obesity
    • NCT02340247
      Completed
      Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass
      Conditions: Severe Obesity
    • NCT00018694
      Withdrawn
      Cholestanol in Humans
      Conditions: Cerebrotendinous Xanthomatosis
    • NCT00465751
      Completed
      Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
      Conditions: Metabolic Syndrome; Familial Hypertriglyceridemia; Familial Combined Hyperlipidemia
    • NCT02876484
      Completed
      Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
      Conditions: Severe Obesity
    • NCT00004346
      Unknown status
      Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
      Conditions: Cerebrotendinous Xanthomatosis
    • NCT04640571
      Not yet recruiting
      Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition
      Conditions: Bile Salt Export Pump (BSEP) Transporter; Polysorbate 80
    • NCT01666223
      Completed
      Effect of Bile Acids on GLP-1 Secretion
      Conditions: Type 2 Diabetes; Obesity
    • NCT01865812
      Completed
      Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
      Conditions: Primary Biliary Cirrhosis
    • NCT01914562
      Completed
      Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
      Conditions: Healthy
    • NCT02314208
      Completed
      Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
      Conditions: Spastic Paraplegia, Hereditary
    • NCT01585025
      Completed
      Obeticholic Acid in Bile Acid Diarrhoea
      Conditions: Primary Bile Acid Malabsorption; Secondary Bile Acid Malabsorption; Chronic Diarrhoea
    • NCT01473524
      Completed
      Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
      Conditions: Primary Biliary Cirrhosis
    • NCT00570765
      Completed
      Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
      Conditions: Liver Cirrhosis, Biliary
    • NCT04270682
      Recruiting
      Study to Evaluate Patients With Cerebrotendinous Xanthomatosis
      Conditions: CTX
    • NCT01674946
      Completed
      Effect of Bile Acids on the Secretion of Satiation Peptides in Humans
      Conditions: Echolocation
    • NCT01904539
      Completed
      Hepatic Impairment Trial of Obeticholic Acid
      Conditions: Hepatic Impairment
    • NCT01933503
      Completed
      Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
      Conditions: Healthy
    • NCT00004442
      Terminated
      Study of Bile Acids in Patients With Peroxisomal Disorders
      Conditions: Infantile Refsum's Disease; Zellweger Syndrome; Bifunctional Enzyme Deficiency; Adrenoleukodystrophy
    • NCT02979210
      Completed
      Infant Fecal Insult Study
      Conditions: Dermatitis
    • NCT03253276
      Completed
      Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
      Conditions: Primary Biliary Cirrhosis
    • NCT03439254
      Active, not recruiting
      Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
      Conditions: Compensated Cirrhosis; Nonalcoholic Steatohepatitis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations